Dive into November’s Topics
Translational Drug Development (TD2)
The Precision Oncology CRO
Welcome to TD2's Monthly Newsletter! As the months go by, our commitment to providing you with cutting-edge cancer research content remains strong. Dive into our handpicked selection of blogs, scientific posters, videos, and get acquainted with our latest services. Together, we aim to advance oncology research and work towards groundbreaking therapies. Stay informed and inspired with us.
PODCAST
The Importance of Metabolic and Proteomic Analyses in Identifying Treatment Pathways for Cancer Patients
Dive into the link between obesity and cancer, the effects of immune checkpoint therapies, and the merging of global metabolic analysis with next-gen sequencing, offering a comprehensive view of exciting field advancements.
FEATURED BLOG
Early Phase Oncology Trial Designs: Model-Based Approach
Discover the importance of Phase I trials in evaluating cancer treatments and how model-based approaches, such as Continual Reassessment Method (CRM) and Dose Escalation with Overdose Control (EWOC), enhance the accuracy of determining the maximum tolerated dose (MTD).
SERVICE SPOTLIGHT
FLOW Cytometry Services
Flow cytometry is essential for preclinical cancer research as it enables the analysis and sorting of cells based on various parameters, aiding in the identification of key cell populations involved in cancer and contributing to the development of targeted therapies and enhanced cancer biology understanding. Strengthen the efficacy of your immunotherapy with TD2’s in-depth analysis capabilities.
Translational Oncology Services
Learn more about TD2's Clinical Trial Management and Regulatory Support Services here.